US 11414494
Anti-GITR antibodies and uses thereof
granted A61KA61K2039/507A61K39/39541
Quick answer
US patent 11414494 (Anti-GITR antibodies and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Aug 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K2039/507, A61K39/39541, A61K45/06, A61P